Skip to content
value.today

Aushon Biosystems Inc.

Total raised
$27 M
5 rounds on record
Latest round
$7 M
Jul 2016
First round on record
Mar 2009
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Aushon Biosystems Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2016$7 MNo. 5$2 to $10 million

Aushon Biosystems Inc.: Raise no. 5, Jul 2016

Investors in this round

10 investors had bought by the notice of Nov 10, 2016: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Peter Honkanen · Executive Officer, Director
  • Susan P. Keefe · Executive Officer
  • Susan Vogt · Executive Officer, Director
  • Bruns P. Grayson · Director
  • Carmichael S. Roberts · Director
  • James Iuliano · Director
  • Thomas P. Mac Mahon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Susan Vogt, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Nov 10, 2016. Read the notice at the SEC.

equitySEC
Nov 2014$8 MNo. 4$2 to $10 million

Aushon Biosystems Inc.: Raise no. 4, Nov 2014

Investors in this round

11 investors had bought by the notice of Nov 26, 2014: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $9 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Peter Honkanen · Executive Officer, Director
  • Susan Vogt · Executive Officer, Director
  • Carmichael S. Roberts · Director
  • James Iuliano · Director
  • Thomas P. Mac Mahon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Susan Vogt, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 26, 2014. Read the notice at the SEC.

equitySEC
Sep 2012$6 MNo. 3$2 to $10 million

Aushon Biosystems Inc.: Raise no. 3, Sep 2012

Investors in this round

7 investors had bought by the notice of Sep 21, 2012: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $8 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John S. Ledoux · Executive Officer
  • Martin Verhoef · Executive Officer, Director
  • Peter Honkanen · Executive Officer, Director
  • Carmichael S. Roberts · Director
  • James A Iuliano · Director
  • Jean-Paul S. Mangeolle · Director
  • Richard A D'Amore · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Martin Verhoef, President. Source: SEC Form D, newest notice filed Sep 21, 2012. Read the notice at the SEC.

equitySEC
Jul 2010$2 MNo. 2Under $2 million

Aushon Biosystems Inc.: Raise no. 2, Jul 2010

Investors in this round

17 investors had bought by the notice of Dec 21, 2011: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Joseph S. Blanchard · Executive Officer
  • Lisa S. Mastrangelo · Executive Officer
  • Peter Honkanen · Executive Officer, Director
  • Carmichael S. Roberts · Director
  • James A Iuliano · Director
  • Jean-Paul S. Mangeolle · Director
  • John Austin · Director
  • Richard A D'Amore · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peter Honkanen, President. Source: SEC Form D, newest notice filed Dec 21, 2011. Read the notice at the SEC.

equitySEC
Mar 2009$5 MNo. 1$2 to $10 million

Aushon Biosystems Inc.: Raise no. 1, Mar 2009

Investors in this round

3 investors had bought by the notice of Mar 20, 2009: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $7 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in De

People named in the notice

  • Kenneth Titlebaum · Executive Officer, Director
  • Peter Honkanen · Executive Officer, Director
  • James Iuliano · Director
  • James Little · Director
  • John Austin · Director
  • Richard A D'Amore · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peter Honkanen, President. Source: SEC Form D, newest notice filed Mar 20, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Aushon Biosystems Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2016).

    SEC Form D · Nov 2016

  • The industry group it chose in its notices: Other.

    SEC Form D · Nov 2016

That is all the official record says: Aushon Biosystems Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Aushon Biosystems Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 17 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Aushon Biosystems Inc.
NameRoleNamed in
Peter HonkanenExecutive officerNov 2016
Susan P. KeefeExecutive officerNov 2016
Susan VogtExecutive officerNov 2016
John S. LedouxExecutive officerSep 2012
Martin VerhoefExecutive officerSep 2012
Joseph S. BlanchardExecutive officerDec 2011
Lisa S. MastrangeloExecutive officerDec 2011
Kenneth TitlebaumExecutive officerMar 2009
Bruns P. GraysonDirectorNov 2016
Carmichael S. RobertsDirectorNov 2016
James IulianoDirectorNov 2016
Peter HonkanenDirectorNov 2016
Susan VogtDirectorNov 2016
Thomas P. Mac MahonDirectorNov 2016
James A IulianoDirectorSep 2012
Jean-Paul S. MangeolleDirectorSep 2012
Martin VerhoefDirectorSep 2012
Richard A D'AmoreDirectorSep 2012
John AustinDirectorDec 2011
James LittleDirectorMar 2009
Kenneth TitlebaumDirectorMar 2009